Compare Sirius XM Holdings Inc (SIRI) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sirius XM Holdings Inc vs Summit Therapeutics Inc — how do they compare? Sirius XM Holdings Inc trades at $30.27 (market cap $10.30B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Sirius XM Holdings Inc and Summit Therapeutics Inc are close in size by market cap, and Sirius XM Holdings Inc pays a 3.53% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| SIRI | SMMT | |
|---|---|---|
Market Cap | $10.30B | $10.48B |
Sector | Media | Health |
52-Week High | $31.22 | $29.32 |
52-Week Low | $19.92 | $13.05 |
Enterprise Value | $19.97B | $9.90B |
Dividend Yield | 3.53% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sirius XM Holdings Inc
SiriusXM Holdings is now composed of two businesses: SiriusXM and Pandora. SiriusXM transmits music, talk shows, sports, and news via its two satellite radio networks, primarily to consumers in vehicles who pay a subscription fee. The firm's radios come preinstalled on a wide range of light vehicles in the U.S. and Canada. The firm acquired Pandora Media in February 2019 via an all-stock transaction. Pandora is a streaming music platform that offers an ad-supported radio option and a paid on-demand service. Liberty Media owns 80% of SiriusXM, traded through its Liberty SiriusXM Group tracking stock.
Read more on SIRI →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
